Research output

  1. Immunomodulation and endothelial barrier protection mediate the association between oral imatinib and mortality in hospitalised COVID-19 patients

    Research output: Contribution to journal › Article › Academic › peer-review

  2. The INVENT COVID trial: a structured protocol for a randomized controlled trial investigating the efficacy and safety of intravenous imatinib mesylate (Impentri®) in subjects with acute respiratory distress syndrome induced by COVID-19

    Research output: Contribution to journal › Article › Academic › peer-review

  3. Neurofilament light increases over time in severe COVID-19 and is associated with delirium

    Research output: Contribution to journal › Article › Academic › peer-review

View all (5) »

ID: 15236818